Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Transcription Factors02:16

Transcription Factors

82.7K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.7K
Factors Affecting Solubility04:01

Factors Affecting Solubility

37.1K
Compared with pure water, the solubility of an ionic compound is less in aqueous solutions containing a common ion (one also produced by dissolution of the ionic compound). This is an example of a phenomenon known as the common ion effect, which is a consequence of the law of mass action that may be explained using Le Chȃtelier’s principle. Consider the dissolution of silver iodide:
37.1K
Transcription Elongation Factors02:35

Transcription Elongation Factors

13.9K
Transcription elongation is a dynamic process that alters depending upon the sequence heterogeneity of the DNA being transcribed. Hence, it is not surprising that the elongation complex's composition also varies along the way while transcribing a gene.
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
13.9K
Factors Affecting Drug Distribution: Miscellaneous Factors01:19

Factors Affecting Drug Distribution: Miscellaneous Factors

988
Drug distribution in the human body is a complex process influenced by various individual factors, including age, pregnancy, obesity, diet, body water composition, pH levels, and specific disease conditions.
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
988
Electrolytes: van't Hoff Factor03:08

Electrolytes: van't Hoff Factor

36.6K
Colligative Properties of Electrolytes
The colligative properties of a solution depend only on the number, not on the identity, of solute species dissolved. The concentration terms in the equations for various colligative properties (freezing point depression, boiling point elevation, osmotic pressure) pertain to all solute species present in the solution. Nonelectrolytes dissolve physically without dissociation or any other accompanying process. Each molecule that dissolves yields one...
36.6K
Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

485
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
485

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Apraxia of lid opening in multiple sclerosis.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2022
Same author

Sphenoid Sinusitis-Associated Optic Neuropathy: A Forgotten Disease.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2022
Same author

Posterior Ischemic Optic Neuropathy Following Recurrent COVID-19 in Prior Bilateral Sequential Nonarteritic Anterior Ischemic Optic Neuropathy.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2022
Same author

Optic nerve sheath diameter and spaceflight: defining shortcomings and future directions.

NPJ microgravity·2022
Same author

Progressive Optic Neuropathy in Cerebellar Ataxia, Areflexia, Optic Atrophy, and Sensorineural Hearing Loss Syndrome: The Importance of Targeted Gene Testing.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2022
Same author

Visual Loss as the Presenting Manifestation of Leptomeningeal Spread of Glioblastoma Multiforme to the Optic Chiasm.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2022

Related Experiment Video

Updated: Feb 1, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

8.9K

The X factor.

Muhammad Musab Shamim1, Aroucha Vickers2, Andrew G Lee3

  • 1Baylor College of Medicine, School of Medicine, Houston, Texas, USA.

Survey of Ophthalmology
|December 7, 2018
PubMed
Summary
This summary is machine-generated.

X-linked adrenoleukodystrophy carriers can present with vision loss and brain lesions mimicking multiple sclerosis. This case highlights bilateral optic atrophy as a potential sign in female carriers.

Keywords:
CarrierX-linkedadrenoleukodystrophymultiple sclerosisoptic neuropathy

More Related Videos

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

12.0K
Fabrication of Silica Ultra High Quality Factor Microresonators
07:51

Fabrication of Silica Ultra High Quality Factor Microresonators

Published on: July 2, 2012

16.9K

Related Experiment Videos

Last Updated: Feb 1, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

8.9K
Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

12.0K
Fabrication of Silica Ultra High Quality Factor Microresonators
07:51

Fabrication of Silica Ultra High Quality Factor Microresonators

Published on: July 2, 2012

16.9K

Area of Science:

  • Neuro-ophthalmology
  • Neurology
  • Genetics

Background:

  • X-linked adrenoleukodystrophy (X-ALD) is a rare genetic disorder affecting the nervous system and adrenal glands.
  • Female carriers of X-ALD can exhibit variable clinical manifestations, often milder than affected males.
  • Distinguishing X-ALD carriers from other neurological conditions like multiple sclerosis is crucial for accurate diagnosis and management.

Observation:

  • A 45-year-old woman presented with progressive, painless peripheral vision loss.
  • Clinical examination revealed bilateral optic atrophy.
  • Brain MRI demonstrated nonenhancing multifocal white matter lesions.
  • Cerebrospinal fluid analysis indicated elevated myelin basic protein levels.

Findings:

  • The patient was diagnosed with the carrier state of X-linked adrenoleukodystrophy.
  • The clinical and radiographic findings mimicked those of multiple sclerosis.
  • This represents the first reported case of bilateral optic atrophy in a female X-ALD carrier in English ophthalmic literature.

Implications:

  • Bilateral optic atrophy should be considered in the differential diagnosis of female carriers presenting with visual disturbances and white matter lesions.
  • Early identification of X-ALD carriers is essential for genetic counseling and potential future therapeutic interventions.
  • This case expands the understanding of the phenotypic spectrum of X-ALD in female carriers.